American Century Companies’s Pacific Biosciences PACB Stock Holding History

American Century Companies’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,602	Closed	-$29.8K	–	2970
2026 Q1	$29.8K	Sell	22,602 -71,461	-76%	-$128K	﹤0.01%	2822
2025 Q4	$176K	Buy	+94,063	New	+$181K	﹤0.01%	2724
2021 Q4	–	Sell	-47,267	Closed	-$1.21M	–	2360
2021 Q3	$1.21M	Buy	47,267 +506	+1%	+$15K	﹤0.01%	1517
2021 Q2	$1.64M	Hold	46,761	–	–	﹤0.01%	1347
2021 Q1	$1.56M	Buy	+46,761	New	+$1.64M	﹤0.01%	1260
2020 Q4	–	Sell	-95,837	Closed	-$946K	–	2017
2020 Q3	$946K	Buy	+95,837	New	+$552K	﹤0.01%	1143

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

American Century Companies's PACB Position: Q2 2026 in Review

American Century Companies sold out of Pacific Biosciences (PACB) in Q2 2026, closing a stake of 22,602 shares — an estimated $29.8K sold.

American Century Companies first reported a position in PACB in Q3 2020 and held it in 6 quarters. The position peaked at $1.64M in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

American Century Companies reported no remaining Pacific Biosciences position as of Q2 2026 after selling out during the quarter.
American Century Companies sold 22,602 Pacific Biosciences shares in Q2 2026, an estimated $29.8K.
American Century Companies first reported a position in Pacific Biosciences in Q3 2020 and held it in 6 quarters.
American Century Companies's Pacific Biosciences position peaked at $1.64M in Q2 2021.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.